More on VTGN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.56 |
|
|||
| Open | $0.56 | ||||
| 52 Wk High | $4.60 | ||||
| 52 Wk Low | $2.81 | ||||
| Day High | $0.58 | ||||
| Day Low | $0.55 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 292,764 | ||||
- Vistagen to Participate in Jefferies 2026 Global Healthcare Conference
- Form 4 Vistagen Therapeutics, For: May 18 Filed by: Angelov Angel S
- Form 3 Vistagen Therapeutics, For: May 18 Filed by: Angelov Angel S
- Form 8-K Vistagen Therapeutics, For: May 18
- Vistagen names Angel Angelov as chief medical officer
- Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer
- Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: TCG Crossover GP II, LLC
- Vistagen to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
- Form 8-K Vistagen Therapeutics, For: May 12
- Vistagen reports preliminary positive safety data from fasedienol trial
Entities mentioned with VTGN
- FDA | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- William Blair | View Related Stories »
- S3 | View Related Stories »
- Dividend | View Related Stories »
- Show More...
